Moreover, Neu2-overexpressed tumor tissue samples showed reduction of pluripotent stem cells markers such as OCT4/SOX2/NANOG and PCS specific marker CD133 at the transcript level (Figure 7F). This evidence concerns the gene NEU2 and neoplasm.